BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 10355766)

  • 21. Tick-borne Langat/mosquito-borne dengue flavivirus chimera, a candidate live attenuated vaccine for protection against disease caused by members of the tick-borne encephalitis virus complex: evaluation in rhesus monkeys and in mosquitoes.
    Pletnev AG; Bray M; Hanley KA; Speicher J; Elkins R
    J Virol; 2001 Sep; 75(17):8259-67. PubMed ID: 11483771
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recombinant and virion-derived soluble and particulate immunogens for vaccination against tick-borne encephalitis.
    Heinz FX; Allison SL; Stiasny K; Schalich J; Holzmann H; Mandl CW; Kunz C
    Vaccine; 1995 Dec; 13(17):1636-42. PubMed ID: 8719513
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A recombinant adenovirus expressing the NS1 nonstructural protein of tick-borne encephalitis virus: some characteristics of the immunologic basis of antiviral action].
    Timofeev AV; Ozherelkov SV; Pronin AV; Deeva AV; Elbert LB; Stefenson JR
    Vopr Virusol; 1997; 42(5):219-22. PubMed ID: 9424847
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protective immune responses to the E and NS1 proteins of Murray Valley encephalitis virus in hybrids of flavivirus-resistant mice.
    Hall RA; Brand TN; Lobigs M; Sangster MY; Howard MJ; Mackenzie JS
    J Gen Virol; 1996 Jun; 77 ( Pt 6)():1287-94. PubMed ID: 8683218
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tick-borne flavivirus NS1 gene: identification of conserved peptides and antigenic analysis of recombinant louping ill virus NS1 protein.
    Venugopal K; Reid HW; Gould EA
    Virus Res; 1994 Feb; 31(2):245-54. PubMed ID: 7513932
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mice immunized with recombinant vaccinia virus expressing dengue 4 virus structural proteins with or without nonstructural protein NS1 are protected against fatal dengue virus encephalitis.
    Bray M; Zhao BT; Markoff L; Eckels KH; Chanock RM; Lai CJ
    J Virol; 1989 Jun; 63(6):2853-6. PubMed ID: 2724416
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An RNA vaccine based on recombinant Semliki Forest virus particles expressing the Cu,Zn superoxide dismutase protein of Brucella abortus induces protective immunity in BALB/c mice.
    Oñate AA; Donoso G; Moraga-Cid G; Folch H; Céspedes S; Andrews E
    Infect Immun; 2005 Jun; 73(6):3294-300. PubMed ID: 15908354
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DNA priming E and NS1 constructs--homologous proteins boosting immunization strategy to improve immune response against dengue in mice.
    Mellado-Sánchez G; García-Cordero J; Luria-Pérez R; Lázaro-Olan L; Santos-Argumedo L; Gutiérrez-Castañeda B; Estrada-García I; Cedillo-Barrón L
    Viral Immunol; 2005; 18(4):709-21. PubMed ID: 16359237
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Humoral responses against coimmunized protein antigen but not against alphavirus-encoded antigens require alpha/beta interferon signaling.
    Hidmark AS; Nordström EK; Dosenovic P; Forsell MN; Liljeström P; Karlsson Hedestam GB
    J Virol; 2006 Jul; 80(14):7100-10. PubMed ID: 16809315
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparative study on the immunotherapeutic efficacy of recombinant Semliki Forest virus and adenovirus vector systems in a murine model for cervical cancer.
    Riezebos-Brilman A; Walczak M; Regts J; Rots MG; Kamps G; Dontje B; Haisma HY; Wilschut J; Daemen T
    Gene Ther; 2007 Dec; 14(24):1695-704. PubMed ID: 17928874
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improved protection against simian immunodeficiency virus mucosal challenge in macaques primed with a DNA vaccine and boosted with the recombinant modified vaccinia virus Ankara and recombinant Semliki Forest virus.
    Martinon F; Brochard P; Ripaux M; Delache B; Aurégan G; Vaslin B; Le Grand R
    Vaccine; 2008 Jan; 26(4):532-45. PubMed ID: 18093703
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recombinant chimeric yellow fever-dengue type 2 virus is immunogenic and protective in nonhuman primates.
    Guirakhoo F; Weltzin R; Chambers TJ; Zhang ZX; Soike K; Ratterree M; Arroyo J; Georgakopoulos K; Catalan J; Monath TP
    J Virol; 2000 Jun; 74(12):5477-85. PubMed ID: 10823852
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protection elicited by a replication-defective adenovirus vector expressing the tick-borne encephalitis virus non-structural glycoprotein NS1.
    Jacobs SC; Stephenson JR; Wilkinson GW
    J Gen Virol; 1994 Sep; 75 ( Pt 9)():2399-402. PubMed ID: 8077939
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protective immunity of E. coli-synthesized NS1 protein of Japanese encephalitis virus.
    Lin CW; Liu KT; Huang HD; Chen WJ
    Biotechnol Lett; 2008 Feb; 30(2):205-14. PubMed ID: 17876533
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immune responses of sheep to louping-ill virus vaccine.
    Shaw B; Reid HW
    Vet Rec; 1981 Dec; 109(24):529-31. PubMed ID: 6280367
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibody response of sheep following administration of louping-ill virus vaccine.
    Reid HW; Pow I
    Vet Rec; 1995 Jun; 136(25):638-9. PubMed ID: 7571273
    [No Abstract]   [Full Text] [Related]  

  • 37. Protective immunity to vaccinia virus induced by vaccination with multiple recombinant outer membrane proteins of intracellular and extracellular virions.
    Fogg C; Lustig S; Whitbeck JC; Eisenberg RJ; Cohen GH; Moss B
    J Virol; 2004 Oct; 78(19):10230-7. PubMed ID: 15367588
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Expression of the NS1 gene of tick-borne encephalitis virus in gram-negative bacteria from the mouse nasopharynx].
    Morozova OV; Maksimova TG; Popova RV; Martsinkevich ON; Bakhvalova VN
    Mol Biol (Mosk); 2001; 35(1):157-62. PubMed ID: 11234376
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of angiogenesis by a Semliki Forest virus vector expressing VEGFR-2 reduces tumour growth and metastasis in mice.
    Lyons JA; Sheahan BJ; Galbraith SE; Mehra R; Atkins GJ; Fleeton MN
    Gene Ther; 2007 Mar; 14(6):503-13. PubMed ID: 17167497
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chimeric Langat/Dengue viruses protect mice from heterologous challenge with the highly virulent strains of tick-borne encephalitis virus.
    Pletnev AG; Karganova GG; Dzhivanyan TI; Lashkevich VA; Bray M
    Virology; 2000 Aug; 274(1):26-31. PubMed ID: 10936085
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.